EPO Patents = 5

Forward Citations = 12

Loading Chart...

11 inventors (with patents filed for the assignee):

John Mulcahy (6 out of 8 patents)

Hassan Pajouhesh (6 out of 6 patents)

Justin Du Bois (5 out of 10 patents)

4. George P Miljanich (5 out of 31 patents)

5. Anton Delwig (4 out of 4 patents)

6. Grant Masaaki Shibuya (4 out of 8 patents)

7. Jacob Beckley (3 out of 3 patents)

8. James Ross Walker (1 out of 17 patents)

9. Matthew Axtman (1 out of 1 patent)

10. Jeffrey E Merit (1 out of 11 patents)

11. Xiang Zhou (1 out of 1 patent)

12. Dennis Monteleone (0 patent)

13. Xiang Zhou (0 patent)

14. Xiang Zhou (0 patent)

15. Justin Dubois (0 patent)

6 patents: Sort by Forward Citations

1. 12162886 - 11,13-modified saxitoxins for the treatment of pain (2024-12-10),

2. 11834456 - 11,13-modified saxitoxins for the treatment of pain (2023-12-05),

3. 11279706 - 11,13-modified saxitoxins for the treatment of pain (2022-03-22),

4. 11236097 - 11,13-modified saxitoxins for the treatment of pain (2022-02-01),

5. 10112953 - 11,13-modified saxitoxins for the treatment of pain (2018-10-30),

6. 10106549 - 10',11′-modified saxitoxins useful for the treatment of pain (2018-10-23),

SiteOne Therapeutics is a biopharmaceutical company developing non-opioid-based therapeutics to treat acute and chronic pain. The company's lead product candidate, ST-2427, is a novel small molecule that selectively targets the NaV1.7 sodium channel, a key mediator of pain signaling. SiteOne's mission is to provide safer and more effective pain management options for patients and healthcare providers.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

6 Patents

#20 in Bozeman, MT

#58 in Montana

#43,794 in US

Bozeman, MT, United States of America

Siteone Therapeutics, Inc.